JOP20170133B1 - عوامل مضادة لمستقبل أنجيوتنسين-1 - Google Patents
عوامل مضادة لمستقبل أنجيوتنسين-1Info
- Publication number
- JOP20170133B1 JOP20170133B1 JOJO/P/2017/0133A JOP20170133A JOP20170133B1 JO P20170133 B1 JOP20170133 B1 JO P20170133B1 JO P20170133 A JOP20170133 A JO P20170133A JO P20170133 B1 JOP20170133 B1 JO P20170133B1
- Authority
- JO
- Jordan
- Prior art keywords
- angiotensin
- receptor antagonists
- compounds
- formula
- gestational
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
يتعلق الاختراع الحالي بالكشف عن مركبات لها الصيغة (I) أو ملح مقبول صيدلانيا منها: AA1-Arg-Val-AA4-AA5-His-Pro-AA8-OH (I), حيث تم تحديد AA1 وAA4 وAA5 وAA8 في المواصفة. ويمكن استخدام مركبات الصيغة (I) لمعالجة ارتفاع ضغط الدم (على سبيل المثال ارتفاع ضغط الدم الناتج عن الحمل)، أو تسمم الحمل، أو مرض كلوي ناتج عن الحمل.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662344831P | 2016-06-02 | 2016-06-02 | |
| EP16185403 | 2016-08-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JOP20170133B1 true JOP20170133B1 (ar) | 2022-03-15 |
Family
ID=58992873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOJO/P/2017/0133A JOP20170133B1 (ar) | 2016-06-02 | 2017-05-29 | عوامل مضادة لمستقبل أنجيوتنسين-1 |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP3464324B1 (ar) |
| JP (1) | JP7139251B2 (ar) |
| BR (1) | BR112018074190A2 (ar) |
| CL (1) | CL2018003324A1 (ar) |
| DK (1) | DK3464324T3 (ar) |
| ES (1) | ES2878153T3 (ar) |
| HU (1) | HUE054334T2 (ar) |
| IL (1) | IL262981B2 (ar) |
| JO (1) | JOP20170133B1 (ar) |
| MX (1) | MX2018014364A (ar) |
| MY (1) | MY191062A (ar) |
| PH (1) | PH12018502440A1 (ar) |
| PL (1) | PL3464324T3 (ar) |
| SI (1) | SI3464324T1 (ar) |
| UA (1) | UA123367C2 (ar) |
| ZA (1) | ZA201807767B (ar) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20151440T1 (hr) | 2008-12-29 | 2016-01-29 | Trevena, Inc. | Efektori beta-arestina i sastavi i metode u kojima se koriste |
-
2017
- 2017-05-29 JO JOJO/P/2017/0133A patent/JOP20170133B1/ar active
- 2017-06-02 EP EP17727220.0A patent/EP3464324B1/en active Active
- 2017-06-02 UA UAA201812609A patent/UA123367C2/uk unknown
- 2017-06-02 SI SI201730820T patent/SI3464324T1/sl unknown
- 2017-06-02 DK DK17727220.0T patent/DK3464324T3/da active
- 2017-06-02 BR BR112018074190A patent/BR112018074190A2/pt not_active Application Discontinuation
- 2017-06-02 MX MX2018014364A patent/MX2018014364A/es unknown
- 2017-06-02 IL IL262981A patent/IL262981B2/en unknown
- 2017-06-02 HU HUE17727220A patent/HUE054334T2/hu unknown
- 2017-06-02 ES ES17727220T patent/ES2878153T3/es active Active
- 2017-06-02 MY MYPI2018002027A patent/MY191062A/en unknown
- 2017-06-02 PL PL17727220T patent/PL3464324T3/pl unknown
- 2017-06-02 JP JP2018561231A patent/JP7139251B2/ja active Active
-
2018
- 2018-11-19 ZA ZA2018/07767A patent/ZA201807767B/en unknown
- 2018-11-20 PH PH12018502440A patent/PH12018502440A1/en unknown
- 2018-11-22 CL CL2018003324A patent/CL2018003324A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3464324B1 (en) | 2021-04-07 |
| DK3464324T3 (da) | 2021-06-28 |
| UA123367C2 (uk) | 2021-03-24 |
| IL262981B1 (en) | 2023-09-01 |
| JP7139251B2 (ja) | 2022-09-20 |
| BR112018074190A2 (pt) | 2019-03-26 |
| ZA201807767B (en) | 2023-04-26 |
| IL262981A (en) | 2018-12-31 |
| IL262981B2 (en) | 2024-01-01 |
| JP2019520331A (ja) | 2019-07-18 |
| ES2878153T3 (es) | 2021-11-18 |
| MY191062A (en) | 2022-05-30 |
| PL3464324T3 (pl) | 2021-10-25 |
| PH12018502440A1 (en) | 2019-09-09 |
| MX2018014364A (es) | 2019-02-14 |
| HUE054334T2 (hu) | 2021-08-30 |
| CL2018003324A1 (es) | 2019-06-07 |
| EP3464324A1 (en) | 2019-04-10 |
| SI3464324T1 (sl) | 2021-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019011911A (es) | Procesos e compuestos intermedios en la preparacion de antagonistas de c5ar. | |
| MY194319A (en) | Aldehyde compounds for treating pulmonary fibrosis, hypoxia, and connective tissue and autoimmune disease | |
| EA201692203A1 (ru) | Соединения, ингибирующие tank-связывающую киназу | |
| EA202090632A1 (ru) | Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов | |
| EA201591420A1 (ru) | Гетероарильные соединения и их применение | |
| BR112016008541A2 (pt) | composições úteis para tratar distúrbios relacionados a kit | |
| JO3515B1 (ar) | مثبطات fgfr4 بيريميدين | |
| MX2016012097A (es) | Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cáncer. | |
| CR20200290A (es) | PÉPTIDOS Y COMPOSICIONES PARA EL TRATAMIENTO DE DAÑO ARTICULAR (Divisional 2015-0466) | |
| EA201790395A1 (ru) | Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы | |
| MX377190B (es) | Uso de un anticuerpo anti-il6r para el tratamiento de la artritis reumatoide. | |
| BR112017006420A2 (pt) | derivados de ácido borônico | |
| TW201612160A (en) | Compounds as CRTH2 antagonist and uses thereof | |
| BR112016014404A2 (pt) | Composições e métodos para tratamento de glaucoma | |
| EP3665175A4 (en) | MUSCARIN M4 ACETYLCHOLIN RECEPTOR ANTAGONISTS | |
| MX379289B (es) | Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. | |
| SA518392179B1 (ar) | مركبات من مضاد لمستقبل سوماتوستاتين وطرق استخدامها | |
| NZ738990A (en) | Cgrp receptor antagonists | |
| DK3242547T3 (da) | Belysning til gartnerianvendelse og andre anvendelser | |
| CY1121624T1 (el) | Παραγωγα 2-αρυλο-4-υδροξυ-1,3-θειαζολιου χρησιμα ως αναστολεις trpm8 για τη θεραπεια της νευραλγιας, του πονου, της χαπ και του ασθματος | |
| LT3458039T (lt) | Trijų komponentų derinys, susidedantis iš grynų 5-ht6 receptoriaus antagonistų, acetilcholinesterazės inhibitorių ir nmda receptoriaus antagonisto | |
| PH12017501214A1 (en) | Cgrp antagonist peptides | |
| ES2394349A8 (es) | Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar | |
| JOP20170133B1 (ar) | عوامل مضادة لمستقبل أنجيوتنسين-1 | |
| GB2550734B (en) | Overcoming the retardation of cement hydration from dispersing agents used in suspension of additives |